tm logo
SPEZIFYA
ABANDONED SECTION 36

on 29 Dec 2021

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

430 E. 29th Street14th FloorNew York, NY 10016

US

Serial Number

1907305 filed on 03rd Jul 2018

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

SPEZIFYA

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosi Read More

Classification Information


Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disorders, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use, namely, immunotherapies; pharmaceutical preparations for human use, namely, T-cells for medical purposes; pharmaceutical preparations for human use, namely, cells for medical purposes for the treatment of cancer and auto-immune diseases; diagnostic pharmaceutical preparations for human use, namely, diagnostic kits consisting primarily of cells for medical laboratory use; pharmaceutical preparations for human use, namely, kits comprised of cells and pharmaceuticals for medical or clinical use for the treatment of cancer and auto-immune diseases;


Classification kind code

11

Mark Details


Serial Number

1907305

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 30th Dec 2020
Advertised
Submitted for opposition 26
on 02th Dec 2020
Approved
Submitted for opposition 27
on 02th Dec 2020
Approval Notice Sent
Submitted for opposition 15
on 17th Apr 2020
Correspondence Created
Submitted for opposition 22
on 29th Aug 2019
Search Recorded
Submitted for opposition 20
on 29th Aug 2019
Examiner's First Report
Submitted for opposition 135
on 15th Feb 2019
Amendment to Application
Submitted for opposition 31
on 04th Jul 2018
Formalized
Submitted for opposition 30
on 03rd Jul 2018
Filed
Submitted for opposition 1
on 03rd Jul 2018
Created